Apixaban Use Among Patients With Severe Renal Impairment

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The Annals of Pharmacotherapy

• Publication date

  2014-11-11

• Fields of study

  Medicine

• Identifiers
  DOI 10.1177/1060028014554446PMID 25388542
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Oral apixaban for the treatment of acute venous thromboembolism.

  2013cited by this paper
• Apixaban versus warfarin in patients with atrial fibrillation.

  2011cited by this paper
• Contraindicated medication use in dialysis patients undergoing percutaneous coronary intervention.

  2009cited by this paper

• The Safety and Effectiveness of Apixaban in Patients with End-Stage Kidney Disease on Dialysis: A Retrospective Observational Study

  2024cites this paper
• Evaluation of outcomes with apixaban use for venous thromboembolism in hospitalized patients with end-stage renal disease receiving renal replacement therapy

  2022cites this paper
• Atrial fibrillation in patients with chronic kidney disease

  2020cites this paper
• [Atrial Fibrillation in Patients on Dialysis Therapy: Epidemiology, Prognosis and Choice of Anticoagulant Therapy].

  2019cites this paper
• Recent Advances for Stroke Prevention in Patients With Atrial Fibrillation and Advanced Kidney Disease

  2019cites this paper
• 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2019cites this paper
• 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

  2019cites this paper
• 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation.

  2019cites this paper
• Oral anticoagulant use in cardiovascular disorders: a perspective on present and potential indications for rivaroxaban

  2018cites this paper
• Orale Antikoagulation: Was Sie bei Senioren beachten sollten

  2018cites this paper
• Indications and appropriate selection of novel oral anticoagulants in patients with atrial fibrillation

  2017cites this paper
• Recent Advances in Stroke Prevention in Patients with Atrial Fibrillation and End-Stage Renal Disease

  2017cites this paper
• Antikoagulation bei Vorhofflimmern im Alter

  2017cites this paper
• Balancing Anticoagulation Decisions in Patients on Dialysis with Atrial Fibrillation.

  2017cites this paper
• Oral Anticoagulants to Prevent Stroke in Nonvalvular Atrial Fibrillation in Patients With CKD Stage 5D: An NKF-KDOQI Controversies Report.

  2017cites this paper
• Comparison of the Safety and Effectiveness of Apixaban versus Warfarin in Patients with Severe Renal Impairment: An Alternative Viewpoint

  2017cites this paper
• Which Patients With Atrial Fibrillation and Chronic Kidney Disease Should Receive Anticoagulation-And With Which Anticoagulant?

  2017cites this paper
• Eteplirsen for the Treatment of Duchenne Muscular Dystrophy: Quality of Evidence Concerns—an Alternative Viewpoint

  2017cites this paper
• [The Choice of Anticoagulant Therapy in Patients With Non-Valvular Atrial Fibrillation and Chronic Kidney Disease].

  2017cites this paper
• A Multicenter Retrospective Analysis of Factors Associated With Apixaban-Related Bleeding in Hospitalized Patients With End-Stage Renal Disease on Hemodialysis

  2017cites this paper
• Epidemiology and Mechanisms of Uremia-Related Cardiovascular Disease.

  2016cites this paper
• [New oral anticoagulants for prophylaxis of stroke. Results of an expert conference on practical use in geriatric patients].

  2016cites this paper
• Atrial Fibrillation in Dialysis Patients: Time to Abandon Warfarin?

  2016cites this paper
• Clinical Application and Pharmacodynamic Monitoring of Apixaban in a Patient with End‐Stage Renal Disease Requiring Chronic Hemodialysis

  2016cites this paper
• Neue orale Antikoagulanzien zur Prophylaxe von Schlaganfällen

  2016cites this paper
• 2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.

  2016cites this paper
• Oral Anticoagulants and Risk of Nephropathy

  2015cites this paper
• Anticoagulation for Atrial Fibrillation in End-stage Kidney Disease

  2015cites this paper